Identified mechanism in the malaria parasite to help it adapt to infected individualsAugust 03, 2007Research has been conducted on the genes of the parasite that play a role during the invasion of red blood cells, as these are very clear targets to develop vaccines against the disease Plasmodium falciparum is responsible for the most severe forms of human malaria. Invasion of host red blood cells is an essential step of the complex life cycle of this parasite. During the process of invasion, P. falciparum, which appears in the stage of a "merozoite", is exposed to antibodies from the immune system. Consequently, the proteins of the merozoite that interact with red blood cells are a possible weak point, and thus a very clear target to develop vaccines. Alfred Cortés, an ICREA researcher working at IRB Barcelona and an expert in molecular parasitology, together with researchers from the National Institute for Medical Research (NIMR) in London, have discovered that the parasite has the ability to switch on and off the expression of some of the proteins it uses to enter its victim's red blood cells. The researchers believe that this ability makes the parasite more adaptable when attempting to invade the cells. The study is published in Friday's issue of Plos Pathogens, the scientific journal with the greatest impact on the field of Parasitology. 30 genes are know to be involved in the process of invasion. Now, the scientists have found that P. falciparum can activate and deactivate the expression of 7 of these genes (and their corresponding proteins) without compromising the parasite's ability to enter normal or modified red blood cells. According to Cortés, this suggests that the varied expression of these genes may help the parasite to escape the host organism's immune responses, although the researcher points out that this is yet to be confirmed. The researchers discovered that the silencing mechanism happens at the epigenetic level, meaning that the parasite stops expressing a certain gene without changing the underlying genetic information, and that the mechanism is flexible, adaptable and easily reversible. This means that the parasite can re-express the proteins relatively easily when infecting another individual or silence them again in a different host, explains Cortés. "We are talking about a very sophisticated adaptation system to the host and our challenge is to find out how this mechanism works at molecular level; that is, we need to figure out which specific epigenetic modifications are associated to activity or to silencing". Another immediate objective is to find out how many of the 30 genes involved in the invasion of red blood cells are active or inactive in parasites found in nature. "Thanks to this study we have been able to identify 7 genes in 4 different genetic families that may be silenced in a specific P. falciparum strain; we suspect, however, that other genes may also be silenced, and we'll follow this up with studies on wild strains of the parasite", concludes Cortés. The scientist, who leads a research line in molecular parasitology in the Genetic Translation Laboratory at IRB Barcelona, emphasises that this study has also revealed that none of these proteins acting on its own would be a suitable candidate to develop a vaccine because the parasite will still succeed in invading the red blood cell to continue its life cycle". Researchers like Alfred Cortés believe that more insight into the biology of this parasite will allow us to design vaccines with a high likelihood of success. Institute for Research in Biomedicine (IRB) |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||